MedTrace Logo

Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in China

NCT05314504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2024-12-19

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of the investigational medical device, injected into the lips.

Conditions

  • Lip Augmentation

Interventions

DEVICE

YVOIRE Y-Solution 360

Cross-linked sodium hyaluronate gel for injection with lidocaine

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-11
Primary Completion
2023-02-23
Completion
2024-02-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314504 on ClinicalTrials.gov